SIMBs + Liposomal Doxorubicin (L-Dox)
High-Risk Neuroblastoma
Pre-clinicalValidated in preclinical studies
Key Facts
Indication
High-Risk Neuroblastoma
Phase
Pre-clinical
Status
Validated in preclinical studies
Company
About Advanced Microbubbles
Advanced Microbubbles is addressing the critical challenge of inefficient drug delivery in oncology, where less than 1% of injected drugs typically reach their target. Their core innovation is the creation of stable, large, monodisperse microbubbles that, when combined with ultrasound, can non-invasively open biological barriers to enable precise delivery of various therapeutic agents. The platform has shown promising preclinical results in models of pancreatic cancer, neuroblastoma, and for blood-brain barrier opening, positioning the company to advance a versatile, drug-agnostic delivery technology.
View full company profileTherapeutic Areas
Other High-Risk Neuroblastoma Drugs
| Drug | Company | Phase |
|---|---|---|
| Neuroblastoma Treatment | Recordati | Commercial |